Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Sexual health news

Show

From To
NIH Awards Will Advance Development of Vaccines for Sexually Transmitted Infections

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced awards to establish four Cooperative Research Centers (CRCs) focused on developing vaccines to prevent sexually transmitted infections (STIs). The grants, totaling $41.6 million over five years, will support collaborative, multidisciplinary research on the bacteria that cause syphilis, gonorrhea and chlamydia. At the end of the program, each center is expected to identify at least one candidate vaccine ready for testing in clinical trials.

Published
10 May 2019
From
National Institute of Allergy and Infectious Diseases
Drug combination could be effective for treatment-resistant gonorrhea

Scientists comparing treatments for gonorrhea have identified a drug combination that could be an effective back-up for patients not responding to current therapy. The research team, from University Hospitals Birmingham, found that a treatment of the antibiotic gentamicin with azithromycin worked almost as well as the currently used ceftriaxone for genital gonorrhea.

Published
07 May 2019
From
Eurekalert Inf Dis
Challenging My Own Bigotry

An HIV-negative gay man confronts his history with men living with the virus.

Published
25 April 2019
From
Poz
PrEP May Offer Psychological Benefits to Gay, Bisexual Men at Risk for HIV

A new study has identified lower rates of sexual anxiety among gay and bisexual men taking pre-exposure prophylaxis (PrEP).

Published
24 April 2019
From
American Journal of Managed Care
Inside Grindr, fears that China wanted to access user data via HIV research

Just a few months after a Chinese gaming company acquired Grindr, a gay dating app, employees of the app learned that the Trump administration was investigating the deal over national security concerns, according to two people familiar with the company. There were worries that China could harvest potentially embarrassing or sensitive private data from the app for espionage purposes. For example, China might be able to find out the HIV status of U.S. military or security personnel who use Grindr.

Published
05 April 2019
From
NBC News
Efavirenz and rifampicin together reduce levels of injectable contraception

Women with HIV receiving depot medroxyprogesterone acetate (DMPA), with efavirenz (EFV)-based ART and rifampicin (RIF)-based TB treatment, had lower MPA plasma levels compared with women not receiving the two drugs.

Published
29 March 2019
From
HIV i-Base
Double-dose levonorgestrel implant does not overcome interaction with efavirenz

Using two levonorgestrel (LNG) implants does not fully overcome the drug-drug interaction with efavirenz (EFV) – according to findings from a pharmacokinetic (PK) evaluation of double-dose LNG in Ugandan women receiving EFV-based ART.

Published
29 March 2019
From
HIV i-Base
Reclaiming my time!

Every time I take my medicine, it is an act of preventing transmission, and survival. Never again will I see myself as ‘unclean’ or ‘a risk to others’. The only time HIV plays a role in my life is when I take my medication before bed.

Published
22 March 2019
From
PrEPing MALTA
Pipeline for Gonorrhea, Chlamydia, and Syphilis

A new report on the sexually transmitted infection (STI) treatment and prevention research “pipeline” points to serious gaps in the development of new tools to address a growing epidemic in the U.S. The report, released today by Treatment Action Group (TAG), provides an assessment of the current research pipeline and calls for a major new investment in STI research.

Published
20 March 2019
From
TAG
Sex clinics show how competition can improve England’s NHS

Patients can walk into clinics without a referral, so providers have to compete for their business.

Published
15 March 2019
From
The Economist (requires free registration)

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.